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The purpose of the present study was to investigate the role of ventral pallidal opioidergic
mechanisms in the control of ethanol intake by studying the effects of acute administration
of morphine on the levels of GABA, glutamate, and dopamine in the ventral pallidum. The
study was conducted using the alcohol-preferring Alko Alcohol (AA) and alcohol-avoiding
Alko Non-Alcohol (ANA) rat lines that have well-documented differences in their voluntary
ethanol intake and brain opioidergic systems. Therefore, examination of neurobiological
differences between the lines is supposed to help to identify the neuronal mechanisms
underlying ethanol intake, since selection pressure is assumed gradually to lead to enrich-
ment of alleles promoting high or low ethanol intake, respectively. The effects of an acute
dose of morphine (1 or 10 mg/kg s.c.) on the extracellular levels of GABA and glutamate
in the ventral pallidum were monitored with in vivo microdialysis. The concentrations of
GABA and glutamate in the dialyzates were determined with a high performance liquid
chromatography system using fluorescent detection, while electrochemical detection was
used for dopamine. The levels of glutamate in the rats injected with morphine 1 mg/kg
were significantly above the levels found in the controls and in the rats receiving morphine
10 mg/kg. Morphine 10 mg/kg also increased the levels of dopamine. Morphine could not,
however, modify the levels of GABA. The rat lines did not differ in any of the effects of
morphine. The data suggest that the glutamatergic and dopaminergic systems in the ven-
tral pallidum may mediate some effects of morphine. Since there were no differences
between the AA and ANA lines, the basic hypothesis underlying the use of the genetic
animal model suggests that the effects of morphine detected probably do not underlie the
different intake of ethanol by the lines and contribute to the control of ethanol intake in
these animals.
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INTRODUCTION
It has been hypothesized that mesolimbic dopamine neurons are
a neural substrate for the reinforcement produced by ethanol and
other substances of abuse (1, 2). Reinforcement from drugs may
also be mediated by a downstream pathway of the nucleus accum-
bens. The mesolimbic dopamine neurons synapse on GABAergic
medium spiny neurons of the nucleus accumbens. One population
of the medium spiny neurons also expressing enkephalin projects
to the ventral pallidum, and consequently the ventral pallidum has
been viewed as a final common path for drug reward and as an
essential convergent point for hedonic and motivational signal-
ing in the brain (3–5). It seems that depression of the output of
medium spiny neurons and activation of the ventral pallidum is
common to various drugs of abuse and could be important for
their reinforcing properties (4).
In accordance with this view, ethanol, amphetamine, cocaine,
and heroin have been shown to suppress extracellular levels of
GABA in the ventral pallidum (6–10), and DAMGO, a µ-opioid
receptor agonist, has been found to inhibit ventral pallidal GABA
release (11). Furthermore, we have recently demonstrated that
ventral pallidal µ-opioidergic and GABAergic receptors partici-
pate in the regulation of ethanol self-administration (12, 13). In
these studies, stimulation of µ-opioid receptors in the ventral pal-
lidum decreased ethanol intake, while blocking of µ-receptors
increased ethanol intake. The GABAA receptor agonist musci-
mol decreased ethanol intake, while administration of the GABAA
receptor antagonist bicuculline had the opposite effect. In other
studies, ethanol-maintained responding has been found to be
reduced by infusions of a ligand binding at GABAA1 receptors
into the ventral pallidum (14). Moreover, excitotoxic lesions of
the ventral pallidum produce changes in the intravenous self-
administration of heroin and cocaine (15, 16), and cocaine injected
into the ventral pallidum increases locomotor activity (17).
Besides the medium spiny neurons from the nucleus accum-
bens, other sources of input to the ventral pallidum are glutamater-
gic projections from the prefrontal cortex as well as mesopallidal
dopaminergic neurons from the ventral tegmental area (18–21).
Both the glutamatergic and dopaminergic neurons innervating
the ventral pallidum have shown some sensitivity to the effects of
drugs of abuse, such as heroin, cocaine, and ethanol, suggesting
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that some effects of these drugs may be mediated by glutamatergic
and dopaminergic mechanisms in the ventral pallidum (7, 22, 23).
The purpose of the present study was to clarify further the
role of ventral pallidal opioidergic mechanisms in the control of
ethanol intake and in the effects of opioids. This was done by
studying the effects of acute administration of morphine on the
extracellular levels GABA, glutamate, and dopamine in the ventral
pallidum using in vivo microdialysis. The studies were conducted
using selective bred alcohol-preferring Alko Alcohol (AA) and
alcohol-avoiding Alko Non-Alcohol (ANA) lines of rats, which
represent two non-overlapping phenotypic distributions of volun-
tary ethanol consumption intake (24). Selectively bred rodent lines
differing in ethanol-related phenotypes have been widely used
to identify the neuronal mechanisms underlying ethanol abuse
(25, 26). Consequently, much effort has been put into the char-
acterization of the AA and ANA rat lines in the search for the
neurochemical correlates of the different levels of ethanol intake
between the two lines (27). The studies are guided by the basic
hypothesis that the selected lines should theoretically differ from
each other only in traits that are related to the selected trait. Hence,
determination of the neurochemical correlates of the different
levels of ethanol intake of the two lines will help to identify the neu-
ronal mechanisms underlying ethanol abuse (27). Earlier studies
have revealed strain-specific differences in the opioidergic systems
as well as in the neurochemical and behavioral effects of opioids
and opioidergic drugs between the AA and ANA rat lines, sug-
gesting a role for the opioidergic systems in their different levels
of ethanol intake (27, 28). The present study further pursued the
opioidergic involvement focusing on the opioidergic systems in
the ventral pallidum of the two rat lines.
MATERIALS AND METHODS
ANIMALS
Male alcohol-preferring AA and alcohol-avoiding ANA rats
(National Institute for Health and Welfare, Helsinki, Finland)
from generations F94–95 were used in the present study. The rats
were from 2 to 4 months of age and weighed from 245 to 392 g
at the time of surgery. The rats were housed in groups of four
or five in plastic cages (Makrolon IV 56 cm× 34 cm× 19 cm)
until the implantation of the microdialysis guide cannula. After
the surgery, each rat was caged individually in a Plexiglas cage
(35 cm× 23 cm× 30 cm) until the end of the experiment with
food [SDS RM1 (E) SQC, Witham, Essex, England] and water
available ad libitum. Ambient temperature was kept at 22± 2°C
and humidity at 55± 10%. The light/dark cycle was 12/12 h (lights
on at 06:00 hours). The experiments were conducted during the
light phase of the cycle. All experimental procedures using animals
were carried out in accordance with the European Communities
Council Directive (2007/526/EEC) and the National Animal Wel-
fare Act and were reviewed and approved according to the Act on
the Use of Animals for Experimental Purposes (62/2006) in the
National Animal Ethics Committee in Finland.
MORPHINE TREATMENT
The rats received morphine acutely 1 or 10 mg/kg s.c. in a volume
of 1 ml/kg in saline. The controls were given an equal volume of
saline.
SURGERY
The rats were anesthetized with halothane (4% during induction
for 4 min and 1.5–2% during the surgery) and attached to a stereo-
tactic frame for implantation of a guide cannula (CMA/12, CMA
Microdialysis, Stockholm, Sweden) into the brain just above the
ventral pallidum. Prior to the surgery, lidocaine was applied to the
surgical site (s.c.). The coordinates for the microdialysis probe, as
given in the atlas of the rat brain by Paxinos and Watson (29),
were 0.8 mm posterior to bregma, 3.2 mm lateral to midline, and
5.1 mm below the dura. They were selected on the basis of the
neurochemical work on the ventral pallidum and hedonic reward
(30). The guide cannula was fastened to the skull with two stain-
less steel screws and dental cement. Body temperature was kept
constant at 37°C during the procedure with a thermostatically
controlled thermal mattress. The rats were administered carpro-
fen (Rimadyl®, 0.1 mg/kg s.c.) before and the day after the surgery.
After the surgery, the rats were held in individual cages. They
were allowed to recover for at least 5 days during which they were
habituated to the experimental procedures by tethering them to a
counterbalancing arm several times.
IN VIVO MICRODIALYSIS
Microdialysis was performed in the home cages. A probe (CMA/12,
membrane length 2 mm, o.d. 0.5 mm, polycarbonate membrane
with a 20 kDa cut-off, CMA Microdialysis, Stockholm, Sweden)
was inserted into the guide cannula at 1600 h on the day preceding
the experiment and left there without perfusion overnight. In the
morning, the rats were tethered to the counterbalancing arm and
a sterilized and modified Ringer solution (148 mM NaCl, 2.7 mM
KCl, 1.2 mM CaCl2, 0.85 mM MgCl2 · 6H2O, pH ~7.00) was per-
fused through the probe with a flow rate of 1.5µl/min using a
CMA 100 microinjection pump. Samples were collected with a
refrigerated sample collector (Univentor 820, Zejtun, Malta) every
20 min. Baseline samples were collected for 2 h; thereafter the rats
were given an injection of morphine, 1 or 10 mg/kg, or saline, and
samples were collected for the next 4 h. The samples were then
divided into three vials for separate analysis of GABA, glutamate,
and dopamine, and stored at−70°C until analysis.
The neuronal origin of GABA was evaluated with high potas-
sium chloride solution (31). After finishing an experiment, 60 mM
KCl (in Ringer) solution was perfused through the probe and sam-
ples were collected for another 2 h. The concentration of GABA
was measured in eight samples.
ANALYSES OF GABA, GLUTAMATE, AND DOPAMINE
The concentrations of GABA, glutamate, and dopamine in the
microdialysis samples were determined with high performance
liquid chromatography (HPLC). The HPLC system consisted of an
isocratic pump with a degasser unit and a refrigerated autoinjector
(Hewlett Packard 1100 series, Palo Alto, CA, USA).
The concentrations of GABA and glutamate were determined
in separate runs using fluorescent detectors (Waters 2475 Multi
λ, Waters, Milford, MA, USA for GABA, and CMA/280, CMA
Microdialysis, Stockholm, Sweden for glutamate) equipped with
an 8µl flow-cell and was operated at an excitation wavelength of
330 nm and emission at 440 nm. The columns were Discovery®RP
Amide C16 150× 3 mm i.d., a particle size of 5µm (Supelco,
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Bellefonte, PA, USA) for GABA, and Hichrom Hypersil H5ODS-
200M 200× 1 mm i.d., a particle size of 5µm (Hichrom, Berk-
shire, UK) for glutamate. The microdialysis samples were mixed
with 2µl of o-phthalaldehyde-β-mercaptoethanol for pre-column
derivatization, and the injection volumes were 4.5 and 14µl for
glutamate and GABA, respectively. The mobile phase for glutamate
was 0.3 M acetic acid buffer containing 16% (v/v) acetonitrile and
0.1 mM Na-ethylenediaminetetraacetic acid (EDTA) at pH 5.85,
and for GABA, 0.1 M acetic acid buffer containing 45% (v/v)
methanol and 0.1 mM Na-EDTA at pH 5.12. The flow rate of
the mobile phase was set to 0.07 and 0.3 ml/min for glutamate
and GABA, respectively. The chromatograms were acquired and
processed with Class VP software v 6.12 (Shimadzu Corporation,
Kyoto, Japan).
Concentrations of dopamine were measured with amperomet-
ric detector (Antec Intro,Antec BV, Leyden, The Netherlands) with
a glassy-carbon VT-03 cell. The glassy-carbon working electrode
was set to a+700 mV vs. Ag/AgCl reference electrode. The column
used was MIC10-3-C18, 100 mm× 1 mm i.d., with a particle size
of 3 mm (Hypersil, LC-Packings, The Netherlands). The mobile
phase was 11% (v/v) methanol in 50 mM phosphate/50 mM citric
acid buffer, 0.15 mM EDTA, 10 mM NaCl, and 0.22 mM sodium
octylsulphonate at pH 4.8. The solution was filtered through a
polyvinylidene fluoride filter with 0.45-mm pores (Millipore, Mil-
ford, MA, USA). The flow rate of the HPLC pump was set to
35µl/min, and the injection volume was 15µl. The limit of detec-
tion for dopamine was 0.35 fmol/ml. The chromatograms were
processed with Waters 820 Maxima Software, v 3.31 (Waters,
Milford, MA, USA).
The microdialysis data (micrometer or nanometer) were con-
verted into percentages of the baseline consisting of the mean of
the four baseline samples, and not corrected for probe recovery.
HISTOLOGY
The positions of the probes were verified by fixing the brain in
10% formalin and making frozen 100µm coronal sections stained
with thionine after completion of the experiments. Prior to the
experiment, it was decided that data would be analyzed only from
the rats in which at least 50% of the probe membrane was verified
to be in the ventral pallidum.
CHEMICALS AND REAGENTS
Morphine-HCl was purchased from University Pharmacy (Hel-
sinki, Finland), 2-bromo-2-chloro-1.1.1trifluoroethane (Halo-
thane BP) from Nicholas Piramal India Ltd. (Chennai, India),
karprofen (Rimadyl Vet) from Vericore Ltd. (Dundee, Eng-
land), and Lidocaine from Orion Pharma (Espoo, Finland). o-
Phthalaldehyde was obtained from Pickering Laboratories (CA,
USA) and 2-mercaptoethanol from Merck KGaA (Darmstadt, Ger-
many). The other common reagents were of HPLC quality and
were obtained from Sigma-Aldrich (St. Louis, MO, USA) or Merck
(Darmstadt, Germany).
STATISTICAL ANALYSIS
The microdialysis data were analyzed with a mixed-design three-
way analysis of variance (ANOVA) with treatment (saline and
morphine) and rat line (AA and ANA) as the between-subjects fac-
tors, and measuring interval (time) as the within-subjects repeated
measure. After finding significant main effects, differences within
the rat lines were examined with a subsequent repeated measures
two-way ANOVA. Post hoc comparisons between the group means
were conducted using Tukey’s test when appropriate. The level of
significance was set at 0.05.
RESULTS
Histological examination of the microdialysis probe placements
showed that all samples had been collected from the central or
caudal portions of the ventral pallidum (Figure 1).
The basal concentrations of GABA in the ventral pallidum were
143.86± 36.30 and 102.60± 20.60 nM for the ANA and AA lines,
respectively. The basal GABA levels did not differ significantly.
Figure 2 shows the effect of an acute dose of morphine on the
extracellular concentration of GABA in the ventral pallidum of
AA and ANA rats. Administration of morphine did not modify the
levels of GABA in either AA or ANA rats. Application of 60 mM
KCl doubled the concentration of GABA relative to the baseline,
verifying that the bulk of the measured concentrations of GABA
were of neuronal origin and hence the concentrations reflected
true changes in neuronal activity.
The basal concentrations of glutamate were 3.48± 0.50 and
4.93± 0.80µM for the ANA and AA lines, respectively. The basal
glutamate levels did not differ significantly. The effect of an acute
dose of morphine on the extracellular concentration of glutamate
in the ventral pallidum of AA and ANA rats is shown in Figure 3.
FIGURE 1 | Schematic diagram of representative microdialysis probe
placements in the ventral pallidum. Not all probe placements are shown.
Each bar represents two individual rats and is fitted to the coronal section
closest to the actual anterior–posterior placement of the probe.
Anterior–posterior placement of the sections is indicated relative to bregma.
Coronal sections were adapted from the atlas of Paxinos and Watson (29).
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FIGURE 2 |The effect of an acute dose of morphine (1 or 10mg/kg s.c.;
groups Mor 1 and Mor 10) on the extracellular concentrations of GABA
in the ventral pallidum of alcohol-preferring AA and alcohol-avoiding
ANA rats. The controls (Sal) received an equal volume of saline. The inset
shows the data as a difference from the controls. The values are expressed
as a percentage of the baseline consisting of the mean of the last four
baseline samples. The moving average of three time points±SEM is given.
Number of animals in each group: AA Sal=8, Mor1=7, Mor10=8; ANA
Sal=7, Mor1=7, and Mor10=8.
Morphine modified the extracellular concentration of glutamate
significantly [F(2,52)= 4.496, p= 0.016, for treatment] in the rats
but not in either line when tested separately. The levels of extracel-
lular glutamate in the rats injected with morphine 1 mg/kg were
significantly (p< 0.05, Tukey’s test) above the levels of the controls
and the rats receiving morphine 10 mg/kg.
The basal concentrations of dopamine in the ventral pal-
lidum were 1.40± 0.30 and 1.49± 0.40 nM for the ANA and
AA lines, respectively. The basal dopamine levels did not differ
significantly. The effect of an acute dose of morphine on the
extracellular concentration of dopamine in the ventral pallidum
of AA and ANA rats is shown in Figure 4. Morphine increased
FIGURE 3 |The effect of an acute dose of morphine (1 or 10mg/kg s.c.;
groups Mor 1 and Mor 10) on the extracellular concentrations of
glutamate in the ventral pallidum of alcohol-preferring AA and
alcohol-avoiding ANA rats. The controls (Sal) received an equal volume of
saline. The inset shows the data as a difference from the controls. The
values are expressed as a percentage of the baseline consisting of the
mean of the last four baseline samples. The moving average of three time
points±SEM is given. Number of animals in each group: AA Sal= 8,
Mor1=7, Mor10=9, ANA Sal=7, Mor1=7, and Mor10=6.
extracellular levels of dopamine [F(2,52)= 4.67, p= 0.014, for
treatment]. Analyzing the lines separately revealed that morphine
increased the level of dopamine significantly in the ANA line
[F(2,24)= 4.629, p= 0.02, for treatment]. Maximal increase was
seen 60 min after administration of the morphine. The concentra-
tions of dopamine in the ANA rats receiving morphine 10 mg/kg
were significantly higher than those in the controls (p< 0.05,
Tukey’s test).
DISCUSSION
The objective of the present investigation was to use the model of
selective bred alcohol-preferring AA and alcohol-avoiding ANA
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FIGURE 4 |The effect of an acute dose of morphine (1 or 10mg/kg s.c.;
groups Mor 1 and Mor 10) on the extracellular concentrations of
dopamine in the ventral pallidum of alcohol-preferring AA and
alcohol-avoiding ANA rats. The controls (Sal) received an equal volume of
saline. The values are expressed as a percentage of the baseline consisting
of the mean of the last four baseline samples. The moving average of three
time points±SEM is given. Number of animals in each group: AA Sal=7,
Mor1=10, Mor10=14, ANA Sal=11, Mor1=7, and Mor10=9.
lines of rats to clarify the role of ventral pallidal opioidergic
mechanisms in the control of ethanol intake and in the effects
of opioids by studying the effects of acute administration of
morphine on the extracellular levels of GABA, glutamate, and
dopamine in the ventral pallidum. In these studies, ventral pal-
lidal levels of glutamate and dopamine were significantly elevated
after morphine. Morphine did not, however, modify the levels of
GABA. The rat lines did not differ significantly in the effects of
morphine. The rats receiving 1 mg/kg of morphine showed higher
levels of glutamate than the other groups.
Drug-induced increase in dopamine release in the nucleus
accumbens is believed to be a critical condition to produce
reinforcement (1). Numerous studies, however, suggest that the
reinforcing effects of ethanol are probably not mediated exclu-
sively through the dopaminergic neurons. For instance, destruc-
tion of the dopaminergic terminals in the nucleus accumbens
does not attenuate acquisition or maintenance of ethanol self-
administration behavior (32, 33). Mechanisms downstream of
the nucleus accumbens may also participate in the mediation of
reinforcement from ethanol. The mesolimbic dopamine neurons
synapse on the GABAergic medium spiny neurons in the nucleus
accumbens (3–5). One population of the medium spiny neu-
rons also expressing enkephalin projects to the ventral pallidum.
According to the prevailing hypothesis, dopamine released in the
nucleus accumbens inhibits GABAergic medium spiny neurons
projecting to the ventral pallidum and the resulting suppression
of GABA release is common to various drugs of abuse and could
be important for their reinforcing properties (4). In accord with
this hypothesis, opiates morphine, and heroin, as well as other
drugs of abuse such as amphetamine, cocaine, and ethanol have
been shown to suppress extracellular levels of GABA or inhibit
GABAergic eISPCs in the ventral pallidum (6–11, 34). In theory,
morphine can induce a reduction in the ventral pallidal levels
of GABA by increasing the release of dopamine in the nucleus
accumbens, thereby increasing inhibitory drive on medium spiny
neurons (35), or by stimulating µ-opioid receptors on medium
spiny neurons in the nucleus accumbens or presynatically in the
ventral pallidum (3, 10, 36). Furthermore, dopaminergic input
from the mesencephalon as well as glutamatergic terminals from
the prefrontal cortex possibly also exert their effects on GABAergic
tone in the ventral pallidum (18, 20, 21).
In the present study, the extracellular levels of GABA in the
ventral pallidum were, however, not modified significantly by mor-
phine in either rat line. There was only a slight trend for increased
levels of GABA during the latter half of the 240 min sampling
time after 10 mg/kg of morphine. Therefore, the present study is
not consistent with earlier studies, where morphine (3 mg/kg) or
self-administered heroin suppressed extracellular levels of GABA
significantly (7, 34), or where DAMGO inhibited GABA release
in the ventral pallidum (11). The finding that morphine did not
modify the ventral pallidal levels of GABA is in contrast to the
hypothesis that the reinforcement from drugs of abuse comes
from suppression of GABA release in the ventral pallidum. The
present data are not in line with our earlier behavioral data either.
We have recently demonstrated that ventral pallidal µ-opioidergic
and GABAergic receptors participate in the regulation of ethanol
self-administration (12, 13). In these studies, stimulation of µ-
opioid receptors in the ventral pallidum decreased ethanol intake,
while blocking µ-receptors increased ethanol intake. The GABAA
receptor agonist muscimol decreased ethanol intake, while admin-
istration of the GABAA receptor antagonist bicuculline had the
opposite effect. The discrepancy between the studies and the rea-
son for the lack of effect from morphine in the present study
remain unclear. It is possible that subtle changes in the extracel-
lular levels of GABA were not detected by the method used in the
present study. This is, however, unlikely, since in another study by
the present authors, ethanol was found to lower the ventral pallidal
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levels of GABA in ANA rats (8). Since both in the present study and
in the study by Caillé and Parsons (7) morphine was administered
subcutaneously, the route of morphine administration probably is
not a confusing factor in the studies.
Glutamatergic afferents from the prefrontal cortex to dopamin-
ergic neurons provide input to the reward circuitry, and glu-
tamatergic projection from the prefrontal cortex to the ventral
pallidum has been described as well (21, 37). The effects of mor-
phine or other drugs of abuse on the overflow of glutamate in
the ventral pallidum are not, however, well characterized. In the
present study, the rats receiving morphine 1 mg/kg showed sig-
nificantly higher levels of glutamate in the ventral pallidum than
what was seen in the controls and in the rats receiving morphine
10 mg/kg, suggesting enhancement of extracellular glutamate after
the lower dose. There was no difference in the effect between the
two lines. We have earlier reported a morphine-induced increase in
the extracellular levels of glutamate in the ventral tegmental area,
which demonstrates the interaction of the opioidergic and gluta-
matergic systems also at the level of ventral tegmental area (38).
The enhancement of ventral pallidal glutamate found here seems
to be concurrent with morphine-induced (1 mg/kg) locomotor
activity (39). Activation of glutamatergic receptors in the ventral
pallidum has earlier been shown to be involved in the hypermotil-
ity response to central nervous system stimulants (40). Somewhat
in line with the present findings, self-administered heroin did not
initially have any effect on the levels of glutamate in the ventral
pallidum in an earlier study, but an increase was detected sub-
sequent to 1 h of self-administration (7). It was speculated the
delayed onset may signify either a long-loop feedback mechanism
or a desensitization of mechanisms regulating glutamatergic input.
Sizemore and others reported small increases in glutamate levels
during cocaine self-administration sessions (22). Ethanol did not,
however, modify significantly the ventral pallidal levels of gluta-
mate (8). Furthermore, in some studies, pallidal microinjections
of pharmacological agents selective to metabotropic glutamate
receptor 7 have been found to modulate the rewarding effects
of cocaine (9). Nevertheless, these findings give support to the
involvement of ventral pallidal glutamatergic mechanisms in the
effects and self-administration of drugs of abuse, but this needs
further characterization.
Dopaminergic innervation of the ventral pallidum arises pre-
dominantly from the ventral tegmental area (20, 41). Morphine
increased the extracellular levels of dopamine in the ventral pal-
lidum in the present study. Although the effect of morphine on
dopamine reached significance in the ANA but not in the AA
line, the conclusion of a different sensitivity of the lines to the
effect of morphine on ventral pallidal dopamine is not justified.
Consequently, the interaction of opioidergic and dopaminergic
mechanisms on the level of ventral pallidum probably does not
play a role in the different levels of intake of ethanol by the rat
lines. Morphine has earlier been reported to increase the release
of dopamine in the nucleus accumbens of AA and ANA rats,
suggesting a role for the mesolimbic dopamine neurons in the
reinforcing effects of morphine (35, 42). Moreover, a morphine-
induced increase in accumbal dopamine was more prominent than
in the ventral pallidum. The two lines did not, however, differ in the
effect of an acute dose of morphine on accumbal dopamine (35). In
studies by others, intraperitoneal administration of ethanol, as well
as systemic and intra-ventral pallidal administration of cocaine
has been shown to increase the extracellular levels of dopamine in
the ventral pallidum, suggesting the involvement of mesopallidal
dopaminergic neurons in the actions of ethanol and cocaine (43,
44). According to the present findings, some effects of morphine
may also be mediated by the mesopallidal dopaminergic neurons.
Microdialysis has been used widely to sample various neu-
rotransmitter substances from the brain. It has, however, been
pointed out that there may be problems in detecting subtle changes
in amino acid levels with the in vivo microdialysis technique, pos-
sibly because a portion of amino acids in the extracellular space is
derived from sources that are not directly involved in neurotrans-
mission (45). This does not necessarily argue against the functional
significance of changes in extracellular amino acid levels in the
brain (46). According to Bourdelais and Kalivas (47), basal extra-
cellular levels of GABA in the ventral pallidum may be maintained,
at least partially, by ongoing neuronal activity, and that at least 50%
of extracellular GABA of the ventral pallidum results from neuro-
transmission. In accordance, this and our previous study showed
that 60 mM KCl doubled the concentration of GABA in the ventral
pallidum, and hence the alterations in the concentrations of GABA
reflected true changes in neuronal activity (8, 31). Our preliminary
findings based on the use of a low calcium Ringer solution or local
infusion of 100µM baclofen support a similar conclusion.
Dialysis sites in the present study were located in the central and
posterior parts of the ventral pallidum. These areas were found to
be responsive for µ-opioid receptor agonists and an antagonist in
a previous study by the present authors (8). Earlier brain map-
ping work has suggested functional differences within the ventral
pallidum in the mediation of reward (3, 30). According to these
studies posterior ventral pallidum µ-opioid neurotransmission in
particular encodes hedonic reward and motivation.
Taken together, in the present study based on the use of
the genetic animal model of alcohol-preferring AA and alcohol-
avoiding ANA rats to clarify the role opioidergic mechanism in
ethanol intake, acute administration of morphine was associated
with increased levels of glutamate and dopamine in the ventral
pallidum, while no changes in the levels of GABA were observed.
The higher pallidal concentrations of glutamate after morphine
are in line with earlier studies. The functional significance of the
detected changes in the levels of glutamate may, however, be chal-
lenged due to the potential problems arising from monitoring
glutamate with microdialysis (45). In contrast, morphine-induced
increase in the levels of dopamine along with similar findings by
others after administration of ethanol and cocaine suggests that
the mesopallidal dopamine neurons may also mediate some effects
of these drugs. Since the AA and ANA rat lines did not differ in the
effects of morphine, the results do not provide additional informa-
tion on the understanding of the role of opioidergic mechanisms
in the different levels of intake of ethanol by the rat lines or more
generally in the control of ethanol intake by rats.
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